Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.29 CAD | +2.63% | +8.85% | +48.00% |
Jun. 03 | Medical Facilities' Black Hills Surgical Hospital to Offer Heart and Vascular Services with Fall 2024 Opening | MT |
May. 09 | Transcript : Medical Facilities Corporation - Shareholder/Analyst Call |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 114.9 | 171.9 | 230 | 155.4 | 168.4 | 229.5 | - | - |
Enterprise Value (EV) 1 | 114.9 | 203.4 | 248.6 | 206 | 168.4 | 229.5 | 229.5 | 229.5 |
P/E ratio | 11.5 x | 19.7 x | 14.8 x | -39.5 x | 9.28 x | 10.9 x | 11.9 x | - |
Yield | 19.3% | 4.03% | 3.07% | 3.88% | - | 2.65% | 2.72% | - |
Capitalization / Revenue | 0.27 x | 0.44 x | 0.56 x | 0.37 x | 0.38 x | 0.52 x | 0.51 x | 0.51 x |
EV / Revenue | 0.27 x | 0.44 x | 0.56 x | 0.37 x | 0.38 x | 0.52 x | 0.51 x | 0.51 x |
EV / EBITDA | 1.19 x | 1.79 x | 2.21 x | 2.15 x | 1.9 x | 2.64 x | 2.62 x | 2.59 x |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 31,106 | 31,106 | 31,106 | 26,200 | 24,856 | 24,377 | - | - |
Reference price 2 | 3.693 | 5.527 | 7.395 | 5.930 | 6.774 | 9.663 | 9.663 | 9.663 |
Announcement Date | 3/12/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/14/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 421.5 | 389.9 | 411.7 | 414.4 | 445.6 | 444.9 | 450.3 | 450.2 |
EBITDA 1 | 96.25 | 96.13 | 104.1 | 72.25 | 88.65 | 86.91 | 87.74 | 88.58 |
EBIT | -3.058 | 67.79 | 77.36 | 34.94 | - | - | - | - |
Operating Margin | -0.73% | 17.39% | 18.79% | 8.43% | - | - | - | - |
Earnings before Tax (EBT) 1 | 4.442 | 41.78 | 50.89 | 17.5 | 52.32 | 54.9 | 58.7 | - |
Net income 1 | 9.824 | 8.813 | 15.5 | -4.405 | 18.5 | 22.3 | 20.3 | - |
Net margin | 2.33% | 2.26% | 3.76% | -1.06% | 4.15% | 5.01% | 4.51% | - |
EPS 2 | 0.3200 | 0.2800 | 0.5000 | -0.1500 | 0.7300 | 0.8900 | 0.8100 | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share 2 | 0.7110 | 0.2228 | 0.2268 | 0.2301 | - | 0.2560 | 0.2630 | - |
Announcement Date | 3/12/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/14/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 116.4 | 102.6 | 102.5 | 102.2 | 107.1 | 109.2 | 109.5 | 104.6 | 122.3 | 108.3 | 107 | 105.4 | 124.3 | 109.3 | 106.7 |
EBITDA 1 | 31.95 | 19.82 | 21.54 | 15.61 | 15.28 | 19.14 | 21.22 | 17.74 | 30.53 | - | 20.5 | 20.2 | 23.9 | 22.5 | 20.7 |
EBIT | 25.5 | 14.68 | 16.46 | 10.42 | -6.627 | 13.5 | - | - | - | - | - | - | - | - | - |
Operating Margin | 21.91% | 14.31% | 16.06% | 10.2% | -6.19% | 12.36% | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | 22.51 | -3.209 | 27.53 | -8.709 | 1.894 | 11.32 | 10.23 | 7.502 | 23.27 | 8.838 | 15.3 | 11.3 | 19.5 | - | - |
Net income 1 | 10.25 | -7.861 | 16.18 | -10.45 | -2.274 | 4.411 | 3.324 | -0.114 | 10.88 | 1.77 | 7.5 | 5.3 | 7.8 | - | - |
Net margin | 8.81% | -7.66% | 15.78% | -10.23% | -2.12% | 4.04% | 3.04% | -0.11% | 8.9% | 1.63% | 7.01% | 5.03% | 6.28% | - | - |
EPS 2 | 0.3300 | -0.2600 | 0.1900 | -0.3500 | -0.0800 | 0.1700 | 0.1300 | -0.0100 | 0.3900 | 0.0700 | 0.3000 | 0.2100 | 0.3100 | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/10/22 | 5/12/22 | 8/11/22 | 11/9/22 | 3/9/23 | 5/11/23 | 8/10/23 | 11/9/23 | 3/14/24 | 5/9/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | 31.5 | 18.5 | 50.7 | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 0.3276 x | 0.1779 x | 0.7013 x | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | 2.490 | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 3/12/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/14/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.00% | 231M | |
-25.47% | 15B | |
-1.80% | 11.99B | |
+3.48% | 11.7B | |
+27.17% | 8.59B | |
-6.29% | 7.5B | |
+6.08% | 6.71B | |
+0.89% | 6.02B | |
-4.31% | 4.28B | |
+11.12% | 4.04B |
- Stock Market
- Equities
- DR Stock
- Financials Medical Facilities Corporation